Tag:
weight-loss medications
News
The FDA has requested that warnings about the risk of vision impairment be added to the labels of weight-loss medications, including Ozempic
The US Food and Drug Administration (FDA) has required manufacturers of GLP-1 medications used for weight loss and diabetes management (Ozempic, Wegovy, Mounjaro and...
News
Ozempic, Wegovy and other GLP-1 agonists: What mistakes do patients make when using these medications?
GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy), liraglutide, dulaglutide, and tirzepatide, are currently considered among the most effective pharmacotherapies for the management of obesity....
Neurology
Study: Weight Loss Medications Reduce Alcohol Dependence
A recent, large-scale genetic study has revealed significant potential: medications already used to treat Type 2 Diabetes and obesity may also be effective in...
News
How do weight-loss medications affect taste receptors and the feeling of satiety?
It seems that the new generation of weight loss medications, such as Wegovy and Mounjaro (GLP-1 agonists), not only reduce hunger but also change...